Lysodren 500 mg (Mitotane Tablet) 500mg

Lysodren 500 mg (Mitotane) is an oral tablet used for managing symptoms in adrenal cortical carcinoma. This prescription medication helps regulate hormone production in adrenal glands. Store at room temperature and follow healthcare provider guidance for safe use.

Strength

500mg

Pack Size

100s

Storage

Ambient

Manufacturer / TM Owner

Corden Pharma Latina S.P.A.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mitotane is primarily used to treat adrenal cortical carcinoma, a rare cancer affecting the adrenal glands. It may also be prescribed off-label for Cushing’s syndrome when other treatments are ineffective. Patients often ask, 'what is Mitotane used for' to understand its role in hormone regulation and cancer management.

Side Effects

Mitotane works by reducing hormone production in the adrenal glands, which can help control symptoms like excessive cortisol. Patients may notice gradual changes in energy levels and hormonal balance over time. It is not a pain reliever but targets the underlying hormonal imbalance.

Precautions & Warnings

Keep Lysodren 500 mg tablets in a cool, dry place away from moisture and direct sunlight. Always handle with care and follow local disposal guidelines for unused or expired medication. Avoid crushing or splitting tablets unless instructed by a healthcare professional.

Avoid Interactions

Mitotane may interact with other medications, including blood thinners, antidepressants, and certain antibiotics. Alcohol and grapefruit products can also affect how Mitotane works in the body. Always inform your doctor about all prescription and over-the-counter drugs you are taking.

Frequently Asked Questions

Mitotane is used to treat adrenal cortical carcinoma and may help manage Cushing’s syndrome by reducing hormone production.

Store at room temperature in a dry place, away from heat and moisture. Keep out of reach of children.

Consult your doctor before combining Mitotane with other drugs, as interactions may occur with blood thinners or antidepressants.

Mitotane is classified as an adrenal cytotoxic agent, often used in cancer treatment but not a traditional chemotherapy.

Take the missed dose as soon as you remember, but skip it if it’s almost time for the next dose. Do not double up.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.